Back to Journals

Biologics: Targets and Therapy


Aims and Scope

Biologics: Targets and Therapy is an international, peer-reviewed, open access journal patho-physiological rationale for, and clinical application of, biologic agents and their biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.

Biologics: Targets and Therapy will no longer consider meta-analyses for publication.

Specific topics covered by the journal include:
• Gene therapy
• Cell therapy
• Antibody-based therapy
• Blood components
• Vaccines
• Hormones
• Cytokines and growth factors
• Toxins
• Peptides

This journal is characterized by the rapid reporting of original research, reviews, basic science, clinical studies and commentaries.

The journal does not accept study protocols. The journal will consider case reports only if they make a valuable and original contribution to the literature. 

When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.